Health News (Reuters)

Novartis wins key European panel's thumbs-up for migraine drug

(Reuters) - Novartis's new migraine drug Aimovig won a key recommendation from a key European panel on Friday, helping open the way for potential sales before the end of the year for a medicine the Swiss drugmaker is counting on to boost growth.

Delhi's proposal to cap drug costs worries Indian hospitals industry

NEW DELHI (Reuters) - Indian authorities have proposed capping medical costs at private hospitals in the capital to help millions of people, but the plan would deal a blow to the multi-billion-dollar healthcare sector already grappling with price control policies.

Leading oncology group wary of Trump drug price proposals

CHICAGO (Reuters) - America's leading group of cancer doctors is wary of new Trump administration proposals for lowering drug costs, warning that patients must not be barred from medicines that could help them.

Physically demanding jobs may shorten men's lives

(Reuters Health) - Despite much evidence that getting lots of physical activity bodes well for long-term health, when it's physical labor on the job, the opposite might be true.

Spine surgery may not be needed to ease back pain from osteoporosis

(Reuters Health) - Patients with acute pain from osteoporosis damage to the spine don't experience any more relief from surgery to inject cement into cracked or broken vertebrae than they would with a sham procedure, a recent trial in The Netherlands suggests.

Utah sues opioid maker Purdue Pharma after settlement talks stall

(Reuters) - Utah's attorney general on Thursday sued OxyContin maker Purdue Pharma LP to hold it responsible for its role in the opioid epidemic after he said talks to reach a settlement between various states and the drugmaker stopped being productive.

Another antibiotic crisis: fragile supply leads to shortages

LONDON (Reuters) - Shortages of some life-saving antibiotics are putting growing numbers of patients at risk and fuelling the evolution of "superbugs" that do not respond to modern medicines, according to a new report on Thursday.

Madrigal Pharma's liver drug succeeds in study, shares soar

(Reuters) - Madrigal Pharmaceuticals Inc's lead experimental drug achieved the main goal of reducing liver fat in patients with fatty liver disease in a mid-stage study, sending its shares surging 66 percent in premarket trading on Thursday.

France's Lactalis tests plant after tainted milk scandal

PARIS (Reuters) - Lactalis is testing production at its Craon plant in northwest France that had been halted because dozens of babies were found ill last year after drinking salmonella-contaminated milk produced at the factory, the company said on Thursday.

African Swine Fever outbreak reported in South Africa

JOHANNESBURG (Reuters) - African Swine Fever (ASF), a severe hemorrhagic disease of pigs, has been reported in South Africa's Northern Cape Province, the department of agriculture said on Thursday.

Indivior subpoenaed by California on opioid addiction treatment

(Reuters) - Britain's Indivior has been subpoenaed by the California Department of Insurance over its blockbuster opioid addiction treatment, Suboxone Film, which is rapidly losing market share due to stiff competition from generic versions.

In China, industry push-back stubs out anti-smoking gains

BEIJING (Reuters) - Earlier this year, the city of Hangzhou, home to the internet giant Alibaba, was poised to join Beijing, Shanghai and a handful of other urban areas in banning smoking in public places, part of a long-running campaign against tobacco use in China.

Minnesota sues opioid maker Insys over improper drug marketing

(Reuters) - Minnesota on Wednesday became the latest state to sue Insys Therapeutics Inc , accusing the drugmaker of illegally marketing a powerful fentanyl-based pain medicine, while a former employee pleaded guilty in New Jersey over bribing doctors to prescribe the drug.

Beyond drugs, it's not clear which ADHD treatments work

(Reuters Health) - Although many doctors offer patients with attention deficit hyperactivity disorder (ADHD) a variety of treatments in addition to drugs, a new review suggests there's not enough evidence that medication alternatives work.